ロード中...
Selegiline and the Treatment of Parkinson's Disease: How patients can benefit from drug therapy
Parkinson's disease involves the progressive degeneration of dopamine neurons in the extrapyramidal motor system. Levodopa, the metabolic precursor of dopamine, relieves symptoms but does not prevent continued cell death. Research suggests that monoamine oxidase B inhibitors, such as selegiline...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1991
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2145357/ https://ncbi.nlm.nih.gov/pubmed/21229030 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|